Exon Skipping Induced by CRISPR-Directed Gene Editing Regulates the Response to Chemotherapy in Non-Small Cell Lung Carcinoma Cells

The authors reported how nuclear factor erythroid 2-related factor 2 disruption led to collateral damage in the form of CRISPR-mediated exon skipping.